Myriam Labopin (M Labopin)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 67

Top Venues

Bone marrow transplantation

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of haematology

Hôpital Saint-Antoine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hôpital Saint-Antoine Feb 01 1990

France

MD MS :: Hematology / EBMT

Publications

Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, Péter Reményi, Edouard Forcade, Gerard Sociè, Patrice Chevallier, Peter A von dem Borne, David Burns, Christophe Schmid, Johan A Maertens, Nicolaus Kröger, Gesine Bug, Mahmoud Aljurf, Jan Vydra, Kazimierz Halaburda, Fabio Ciceri, Florent Malard
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT. Bone marrow transplantation (2024)
Azza Ismail, Rosamaria Nitti, Basil Sharrack, Manuela Badoglio, Pascale Ambron, Myriam Labopin, Alexander Tobias, John A Snowden, Raffaella Greco
ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP). Bone marrow transplantation (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation 59 (3) (2024)
Gesine Bug, Myriam Labopin, Alexander Dmitrievich Kulagin, Didier Blaise, Anna Maria Raiola, Jan Vydra, Simona Sica, Mi Kwon, Lucía López Corral, Stefania Bramanti, Peter A von dem Borne, Maija Itälä-Remes, Massimo Martino, Yener Koc, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Florent Malard
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT). Bone marrow transplantation (2024)
Razan Mohty, Abdul-Hamid Bazarbachi, Myriam Labopin, Aleksandra Holowiecka, Nicolaus M Kröger, Jan J Cornelissen, Didier Blaise, Gerard Sociè, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter A von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Florent Malard
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone marrow transplantation (2024)
Ali Bazarbachi, Myriam Labopin, Nour M Moukalled, Nicolaus M Kröger, Christina Rautenberg, Johannes Schetelig, Juergen Finke, Igor Wolfgang Blau, Didier Blaise, Matthias Stelljes, Matthias Eder, Uwe Platzbecker, Peter Dreger, Wolfgang Andreas Bethge, Johanna Tischer, David Burns, Henrik Sengeløv, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Florent Malard
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation 59 (3) (2024)
Ali Bazarbachi, Myriam Labopin, Nour M Moukalled, Nicolaus M Kröger, Christina Rautenberg, Johannes Schetelig, Juergen Finke, Igor Wolfgang Blau, Didier Blaise, Matthias Stelljes, Matthias Eder, Uwe Platzbecker, Peter Dreger, Wolfgang Andreas Bethge, Johanna Tischer, David Burns, Henrik Sengeløv, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Florent Malard
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Enrico Maffini, Myriam Labopin, Nicolaus Kröger, Juergen Finke, Matthias Stelljes, Thomas Schroeder, Hermann Einsele, Johanna Tischer, Martin Bornhäuser, Wolfgang Andreas Bethge, Arne Brecht, Wolf Rösler, Peter Dreger, Kerstin Schäfer-Eckart, Jakob R Passweg, Igor Wolfgang Blau, Arnon Nagler, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation 59 (7) (2024)
Rama Al Hamed, Myriam Labopin, De-Pei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob R Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz Caballer, Didier Blaise, Péter Reményi, Urs Schanz, Aleksandra Holowiecka, Norbert-Claude Gorin, Fabio Ciceri, Florent Malard
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. Bone marrow transplantation (2024)
Enrico Maffini, Myriam Labopin, Nicolaus Kröger, Juergen Finke, Matthias Stelljes, Thomas Schroeder, Hermann Einsele, Johanna Tischer, Martin Bornhäuser, Wolfgang Andreas Bethge, Arne Brecht, Wolf Rösler, Peter Dreger, Kerstin Schäfer-Eckart, Jakob R Passweg, Igor Wolfgang Blau, Arnon Nagler, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation (2024)
Eugenia Gkaliagkousi, Ioanna Sakellari, Myriam Labopin, Martin Bornhäuser, Rose-Marie Hamladji, Jochen Casper, Matthias Edinger, Pavel Zák, Ibrahim Yakoub Agha, Fabio Ciceri, Thomas Schroeder, Tsila Zukerman, Guido Kobbe, Moshe Yeshurun, Franco Narni, Juergen Finke, Jose Luiz Diez-Martin, Ana Berceanu, Inken Hilgendorf, Mareike Verbeek, Attilio Olivieri, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Florent Malard
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). Bone marrow transplantation (2023)
Rémy Duléry, Florent Malard, Eolia Brissot, Anne Banet, Simona Sestili, Ramdane Belhocine, Martina Calabro, Zoé Van de Wyngaert, Agnès Bonnin, Tounes Ledraa, Ollivier Legrand, Myriam Labopin, Elodie Capderou, Ariel Cohen, Stéphane Ederhy, Florent Malard
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation. Bone marrow transplantation (2023)
Xavier Poire, Myriam Labopin, Emmanuelle Polge, Arnold Ganser, Gerard Sociè, Tobias Gedde-Dahl, Edouard Forcade, Jürgen Finke, Yves Chalandon, Claude-Eric Bulabois, Ibrahim Yakoub-Agha, Mahmoud Aljurf, Nicolaus Kröger, Igor Wolfgang Blau, Arnon Nagler, Aleksandra Holowiecka, Florent Malard
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype. Bone marrow transplantation (2023)
Fréderic Baron, Annalisa Ruggeri, Christophe Peczynski, Myriam Labopin, Jean-Henri Bourhis, Mauricette Michallet, Patrice Chevallier, Jaime Sanz Caballer, Edouard Forcade, Riccardo Saccardi, Victoria Potter, Eliane Gluckman, Arnon Nagler, Florent Malard
Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Sebastian Giebel, Myriam Labopin, Gerard Sociè, Mahmoud Aljurf, Urpu Salmenniemi, Hélène Labussière-Wallet, Micha Srour, Nicolaus M Kröger, Mohsen Al Zahrani, Bruno Lioure, Péter Reményi, Mutlu Arat, Jean Henri Bourhis, Grzegorz Helbig, Abdelghani Tbakhi, Edouard Forcade, Anne Huynh, Eolia Brissot, Alexandros Spirydonidis, Bipin P Savani, Zinaida Perić, Arnon Nagler, Florent Malard
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Sebastian Giebel, Myriam Labopin, Mohamed Houhou, Denis Caillot, Juergen Finke, Didier Blaise, Nathalie Fegueux, Mark Ethell, Jan J Cornelissen, Edouard Forcade, Ibrahim Yakoub Agha, Federico Lussana, Johan Maertens, Jean Henri Bourhis, Pavel Jindra, Norbert-Claude Gorin, Arnon Nagler, Florent Malard
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Pal Remenyi, Edouard Forcade, Nicolaus M Kröger, Gerard Sociè, Charles F Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Aleksandra Holowiecka, Arnon Nagler, Fabio Ciceri, Florent Malard
Improved post-transplant outcomes in recent years for AML patients with FLT3-ITD and wild-type NPM1: a report from the EBMT acute leukemia working party. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gesine Bug, Myriam Labopin, Riitta Niittyvuopio, Matthias Stelljes, Hans Christian Reinhardt, Inken Hilgendorf, Nicolaus M Kröger, Ain Kaare, Wolfgang Andreas Bethge, Kerstin Schäfer-Eckart, Mareike Verbeek, Stephan Mielke, Kristina Carlson, Ali Bazarbachi, Alexandros Spirydonidis, Bipin N Savani, Arnon Nagler, Florent Malard
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Giuliano Filippini Velázquez, Myriam Labopin, Johanna Tischer, Anna Maria Raiola, Emanuele Angelucci, Alexander Dmitrievich Kulagin, Piero Galieni, Arancha Bermúdez, Claude-Eric Bulabois, Nicolaus M Kröger, José Luis Díez-Martín, Mi Kwon, Arnon Nagler, Christophe Schmid, Fabio Ciceri, Florent Malard
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation (2023)
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Alexander Dmitrievich Kulagin, Andrea Velardi, Jaime Sanz Caballer, Hélène Labussière-Wallet, Victoria Potter, Jürgen H E Kuball, Simona Sica, Elena Parovichnikova, Wolfgang Andreas Bethge, Natacha Maillard, Uwe Platzbecker, Friedrich Stölzel, Fabio Ciceri, Florent Malard
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
Klaus Hirschbühl, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Jean Henri Bourhis, Gerard Sociè, Edouard Forcade, Ibrahim Yakoub Agha, Hélène Labussière-Wallet, Wolfgang Andreas Bethge, Patrice Chevallier, Sarah Bonnet, Matthias Stelljes, Alexandros Spirydonidis, Zinaida Perić, Eolia Brissot, Bipin Savani, Sebastian Giebel, Christophe Schmid, Fabio Ciceri, Arnon Nagler, Florent Malard
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Jia Chen, Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Alessandra Tucci, Jan Cornelissen, Ellen Meijer, Irma Khevelidze, Emmanuelle Polge, Depei Wu, Florent Malard, Norbert-Claude Gorin
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone marrow transplantation (2023)
Imane Abou Dalle, Myriam Labopin, Nicolaus M Kröger, Thomas Schroeder, Juergen Finke, Matthias Stelljes, Andreas Neubauer, Didier Blaise, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Edouard Forcade, Maija Itäla-Remes, Peter Dreger, Gesine Bug, Jakob Passweg, Michael Heuser, Goda Choi, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Ali Bazarbachi, Florent Malard
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
Alexandros Spirydonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles F Craddock, Eva Maria Wagner-Drouet, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald G Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus M Kröger, Victoria Potter, Edouard Forcade, Jakob R Passweg, Régis Peffault de Latour, Johan A Maertens, Keith M O Wilson, Jean Henri Bourhis, Juergen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin P Savani, Arnon Nagler, Fabio Ciceri, Florent Malard
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Jaime Sanz Caballer, Myriam Labopin, Thomas Pabst, Jurjen Versluis, Gwendolyn Van Gorkom, Ellen Meijer, Tobias Gedde-Dahl, Juan Montoro Gómez, William Arcese, José Antonio Pérez-Simón, Nicolaas Schaap, Johan Maertens, Radovan Vrhovac, Francesco Lanza, Norbert-Claude Gorin, Florent Malard, Fabio Ciceri
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Eugenia Gkaliagkousi, Myriam Labopin, Ioanna Sakellari, Urpu Salmenniemi, Ibrahim Yakoub Agha, Victoria Potter, Ana Berceanu, Alessandro Rambaldi, Inken Hilgendorf, Nicolaus M Kröger, Stephan Mielke, Tsila Zukerman, Jaime Sanz Caballer, Alessandro Busca, Hakan Ozdogu, Achilles Anagnostopoulos, Bipin P Savani, Sebastian Giebel, Ali Bazarbachi, Alexandros Spirydonidis, Arnon Nagler, Florent Malard
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). Bone marrow transplantation 57 (12) (2022)
Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, Nicolaus M Kröger, Mutlu Arat, Keith M O Wilson, Jacques-Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis D Kottaridis, Ibrahim Yakoub Agha, Rocio Parody Porras, Eva Maria Wagner, Aleksandra Holowiecka, Francesco Lanza, Arnon Nagler, Florent Malard
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation 57 (10) (2022)
Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, Didier Blaise, Anna Maria Raiola, Jiri Pavlu, Luca Castagna, Gerard Sociè, Yves Chalandon, Massimo Martino, Friedrich Stölzel, Gesine Bug, Benedetto Bruno, Radovan Vrhovac, Amandine Charbonnier, Attilio Olivieri, Jacques-Olivier Bay, Concepcion Herrera Arroyo, Ibrahim Yakoub-Agha, Daniele Avenoso, Andreas Neubauer, Stéphanie Nguyen, Edouard Forcade, Eolia Brissot, Bipin Savani, Arnon Nagler, Florent Malard
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. Bone marrow transplantation 57 (9) (2022)
Ivetta Danylesko, Christophe Peczynski, Myriam Labopin, Emmanuelle Polge, Johanna Tischer, Didier Blaise, Yener Koc, Zafer Gülbas, Fabio Ciceri, Mutlu Arat, Luca Castagna, Benedetto Bruno, Anna Maria Raiola, Carmen Botella-Garcia, Bipin N Savani, Simona Piemontese, Annalisa Ruggeri, Arnon Nagler, Florent Malard
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT. Bone marrow transplantation 57 (8) (2022)
Alexandros Spirydonidis, Myriam Labopin, Eolia Brissot, Ivan Sergeevich Moiseev, Jan Cornelissen, Goda Choi, Fabio Ciceri, Jan Vydra, Péter Reményi, Montserrat Rovira, Ellen Meijer, Hélène Labussière-Wallet, Didier Blaise, Gwendolyn van Gorkom, Nicolaus M Kröger, Yener Koc, Sebastian Giebel, Ali Bazarbachi, Bipin P Savani, Arnon Nagler, Florent Malard
Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 57 (12) (2022)
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel, Marie Robin, Natacha Maillard, Marie Ouachée-Chardin, Edouard Forcade, Xavier Poire, Sylvain Chantepie, Anne Huynh, Claude Eric Bulabois, Mathieu Leclerc, Sébastien Maury, Patrice Chevallier, Thomas Cluzeau, Jean-Baptiste Mear, Jérôme Cornillon, Karin Bilger, Célestine Simand, Yves Beguin, Marie-Thérèse Rubio, Ibrahim Yakoub-Agha, Eolia Brissot
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC. Bone marrow transplantation (2022)
Fanny Rialland, Audrey Grain, Myriam Labopin, Gerard Michel, Virginie Gandemer, Catherine Paillard, Cécile Pochon, Laurence Clement, Eolia Brissot, Charlotte Jubert, Anne Sirvent, Pierre-Simon Rohrlich, Dominique Plantaz, Jean-Hugues Dalle, Florent Malard
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial. Bone marrow transplantation 57 (11) (2022)
Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, Thomas Schroeder, Nicolaus M Kröger, Mutlu Arat, Bipin P Savani, Alexandros Spirydonidis, Rose-Marie Hamladji, Victoria Potter, Ana Berceanu, Ibrahim Yakoub Agha, Alessandro Rambaldi, Hakan Ozdogu, Jaime Sanz Caballer, Arnon Nagler, Florent Malard
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2022)
Florent Malard, Didier Blaise, Régis Peffault de Latour, Myriam Labopin, Jean Henri Bourhis, Benedicte Bruno, Patrice Ceballos, Marie Detrait, Virginie Gandemer, Anne Huynh, Faezeh Izadifar-Legrand, Charlotte Jubert, Hélène Labussière-Wallet, Delphine Lebon, Sébastien Maury, Catherine Paillard, Cécile Pochon, Cecile Renard, Fanny Rialland, Pascale Schneider, Anne Sirvent, Kobby Asubonteng, Gwennaëlle Guindeuil, Ibrahim Yakoub Agha, Jean-Hugues Dalle
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study. Bone marrow transplantation (2022)
Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, Emanuele Angelucci, Mutlu Arat, Mahmoud Aljurf, Simona Sica, Jiri Pavlu, Gerard Sociè, Paolo Bernasconi, Luigi Rigacci, Johanna Tischer, Antonio Maria Risitano, Montserrat Rovira, Riccardo Saccardi, Pietro Pioltelli, Gwendolyn Van Gorkom, Antonin Vitek, Bipin N Savani, Alexandros Spirydonidis, Zinaida Perić, Arnon Nagler, Florent Malard
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 57 (3) (2022)
Avichai Shimoni, Myriam Labopin, Emanuele Angelucci, Didier Blaise, Fabio Ciceri, Yener Koc, Zafer Gülbas, J L Diez-Martin, Benedetto Bruno, Luca Castagna, Massimo Martino, Montserrat Rovira, Florent Malard, Arnon Nagler
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML. Bone marrow transplantation 57 (3) (2022)
Fréderic Baron, Myriam Labopin, Johanna Tischer, Fabio Ciceri, Anna Maria Raiola, Didier Blaise, Simona Sica, Jan Vydra, Renato Fanin, Jose Luis Diez-Martin, Claude Eric Bulabois, Friedrich Stölzel, Alessandro Busca, Pavel Jindra, Yener Koc, Patrice Chevallier, Edouard Forcade, Wolf Rösler, Jakob Passweg, Alexander Dmitrievich Kulagin, Angelo Michele Carella, Celestine Simand, Ali Bazarbachi, Pietro Pioltelli, Arnon Nagler, Florent Malard
Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. Bone marrow transplantation 57 (11) (2022)
Arnon Nagler, Myriam Labopin, Xiao-Jun Huang, Didier Blaise, William Arcese, Mercedes Colorado Araujo, Gerard Sociè, Edouard Forcade, Fabio Ciceri, Jonathan Canaani, Sebastian Giebel, Eolia Brissot, Jaime Sanz Caballer, Ali Bazarbachi, Ibrahim Yakoub Agha, Florent Malard
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT. Bone marrow transplantation 57 (4) (2022)
Giorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, Anna Maria Raiola, Didier Blaise, Annalisa Ruggeri, Yener Koc, Zafer Gülbas, Antonin Vitek, Simona Sica, Jose Luiz Diez-Martin, Luca Castagna, Benedetto Bruno, Montserrat Rovira, Ivan Sergeevich Moiseev, Massimo Martino, Giovanni Grillo, Mercedes Colorado Araujo, Claude Eric Bulabois, Stéphanie Nguyen, Gerard Sociè, Mutlu Arat, Jiri Pavlu, Johanna Tischer, Hans Martin, Lucia Lopez Corral, Goda Choi, Edouard Forcade, Andrew McDonald, Fabrizio Pane, Ali Bazarbachi, Fabio Ciceri, Arnon Nagler, Mohamad Mohty
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 57 (4) (2022)
Anne Banet, Ali Bazarbachi, Myriam Labopin, Nicolas Stocker, Rémy Duléry, Florent Malard, Zoé Van de Wyngaert, Alexis Genthon, Mara Memoli, Ollivier Legrand, Agnes Bonnin, Tounes Ledraa, Ramdane Belhocine, Simona Sestili, Jean El-Cheikh, Florent Malard, Eolia Brissot
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation. Bone marrow transplantation (2022)
Arnon Nagler, Christophe Peczynski, Bhagirathbhai R Dholaria, Myriam Labopin, Thomas Valerius, Peter Dreger, Nicolaus Kröger, Hans Christian Reinhardt, Jürgen Finke, Georg-Nikolaus Franke, Fabio Ciceri, Mareike Verbeek, Igor Wolfgang Blau, Martin Bornhäuser, Alexandros Spirydonidis, Gesine Bug, Ali Bazarbachi, Christophe Schmid, Ibrahim Yakoub-Agha, Bipin N Savani, Florent Malard
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone marrow transplantation 57 (7) (2022)
Eduardo Rodríguez Arbolí, Myriam Labopin, Matthias Eder, Arne Brecht, Igor Wolfgang Blau, Anne Huynh, Edouard Forcade, Johanna Tischer, Wolfgang Andreas Bethge, Sergey Bondarenko, Mareike Verbeek, Claude Eric Bulabois, Hermann Einsele, Friedrich Stölzel, Bipin Savani, Alexandros Spirydonidis, Ali Bazarbachi, Sebastian Giebel, Eolia Brissot, Christophe Schmid, Arnon Nagler, Florent Malard
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis. Bone marrow transplantation 57 (6) (2022)
Jesus Duque-Afonso, Jürgen Finke, Myriam Labopin, Charles F Craddock, Rachel Protheroe, Panagiotis Kottaridis, Eleni Tholouli, Jenny L Byrne, Kim Orchard, Urpu Salmenniemi, Inken Hilgendorf, Hannah Hunter, Emma Nicholson, Adrian J C Bloor, John A Snowden, Mareike Verbeek, Andrew Clark, Bipin N Savani, Alexandros Spirydonidis, Arnon Nagler, Florent Malard
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone marrow transplantation 57 (8) (2022)
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, Myriam Labopin, Nicolaus M Kröger, Gerard Sociè, Tobias Gedde-Dahl, Victoria Potter, Thomas Schroeder, Uwe Platzbecker, Arnold Ganser, Didier Blaise, Urpu Salmenniemi, Johan Maertens, Charles F Craddock, Hélène Labussière-Wallet, Ibrahim Yakoub Agha, Bipin P Savani, Florent Malard
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT. Bone marrow transplantation 57 (12) (2022)
Mohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, Fabio Ciceri, Jürgen Finke, Benedetto Bruno, Martin Bornhäuser, Tobias Gedde-Dahl, Hélène Labussière-Wallet, Riitta Niittyvuopio, Thomas Valerius, Emanuele Angelucci, Arne Brecht, Dolores Caballero, Jürgen H E Kuball, Victoria Potter, Christoph Schmid, Johanna Tischer, Tsila Zukerman, Fabio Benedetti, Didier Blaise, Jose Luis Diez-Martin, Jaime Sanz Caballer, Annalisa Ruggeri, Eolia Brissot, Bipin P Savani, Sebastian Giebel, Arnon Nagler, Florent Malard
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. Bone marrow transplantation 56 (9) (2021)
Christophe Schmid, Myriam Labopin, Nicolaas Schaap, Joan Hendrik Veelken, Arne Brecht, Michael Stadler, Juergen Finke, Fréderic Baron, Matthew Collin, Gesine Bug, Qamar-Un-Nisa Chaudhry, Didier Blaise, Johanna Tischer, Adrian J C Bloor, Alexander Dmitrievich Kulagin, Sebastian Giebel, Norbert-Claude Gorin, Aleksandra Holowiecka, Fabio Ciceri, Bipin P Savani, Arnon Nagler, Florent Malard
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia. Bone marrow transplantation (2021)
Annalisa Ruggeri, Myriam Labopin, Emanuele Angelucci, Didier Blaise, Fabio Ciceri, Yener Koc, Patrizia Chiusolo, Jose Luiz Diez-Martin, Zafer Gülbas, Luca Castagna, Benedetto Bruno, Mutlu Arat, Massimo Martino, Arnon Nagler, Mohamad Mohty
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT. Bone marrow transplantation 56 (8) (2021)
Diana M Greenfield, Nina Salooja, Christophe Peczynski, S van der Werf, Hélène M Schoemans, K Hill, A Cortelezzi, Maria Teresa Lupo Stanghellini, Z N Özkurt, M Arat, B Metzner, P Turlure, Alicia Rovo, G Socié, Florent Malard, Arnon Nagler, Nicolaus M Kröger, Peter Dreger, Myriam Labopin, Thang Sieu Han, A Tichelli, R Duarte, G Basak, John A Snowden
Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study. Bone marrow transplantation 56 (11) (2021)
Johanna Waidhauser, Myriam Labopin, Aleksandra Holowiecka, Nicolaus Kröger, Jan Cornelissen, Tobias Gedde-Dahl, Gwendolyn Van Gorkom, Jürgen Finke, Montserrat Rovira, Nicolaas Schaap, Eefke Petersen, Dietrich Beelen, Donald Bunjes, Bipin Savani, Christophe Schmid, Arnon Nagler, Florent Malard, null null
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone marrow transplantation 56 (10) (2021)
Raffaella Greco, Alexander Tobias, Joachim Burman, Nicoletta Del Papa, Jeska de Vries-Bouwstra, Dominique Farge, Jörg Henes, Majid Kazmi, Kirill Kirgizov, Paolo Antonio Muraro, Elena Ricart, Montserrat Rovira, Riccardo Saccardi, Basil Sharrack, Emilian Snarski, Barbara Withers, Helen Jessop, Claudia Boglione, Ellen Kramer, Manuela Badoglio, Myriam Labopin, Kim Orchard, Selim Corbacioglu, Qamar-Un-Nisa Chaudhry, Malgorzata Mikulska, Rafael De la Cámara LLanzá, John A Snowden, null null
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone marrow transplantation 56 (7) (2021)
Fréderic Baron, Maud Ngoya, Myriam Labopin, Jan J Cornelissen, Arnold Ganser, Edouard Forcade, Henrik Sengeloev, Gerard Sociè, Didier Blaise, Martin Bornhäuser, Thomas Valerius, Hans Christian Reinhardt, Nicolaus M Kröger, Annalisa Ruggeri, Arnon Nagler, Florent Malard
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT. Bone marrow transplantation 56 (11) (2021)
Akshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, Hemant S Murthy, Pinki Prasad, Hesham Eissa, Paul A Carpenter, Mehdi Hamadani, Myriam Labopin, Hélène M Schoemans, André Tichelli, Rachel Phelan, Betty K Hamilton, David Buchbinder, Annie Im, Rebecca Hunter, Ruta Brazauskas, Linda J Burns
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. Bone marrow transplantation 56 (4) (2021)
Florent Malard, Marta Lisa Battista, Didier Blaise, Elisabetta Calore, Simone Cesaro, Natalia Maximova, Katia Perruccio, Cecile Renard, Robert Wynn, Marco Zecca, Myriam Labopin, Raj Hanvesakul, Vian Amber, Robert J Ryan, Sarah Lawson, Fabio Ciceri
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone marrow transplantation 56 (10) (2021)
Arnon Nagler, Fréderic Baron, Myriam Labopin, Emmanuel Polge, Jordi Esteve, Ali Bazarbachi, Eolia Brissot, Gesine Bug, Fabio Ciceri, Sebastian Giebel, Maria H Gilleece, Norbert-Claude Gorin, Francesco Lanza, Zinaida Peric, Annalisa Ruggeri, Jaime Sanz Caballer, Bipin P Savani, Christoph Schmid, Roni Shouval, Alexandros Spirydonidis, Jurjen Versluis, Mohamad Mohty
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT. Bone marrow transplantation 56 (1) (2020)
J Loke, Myriam Labopin, Charles F Craddock, Dietger Niederwieser, J Cornelissen, B Afansayev, P Jindra, J Maertens, Didier Blaise, K Boriskina, M Gramatzki, A Ganser, B Savani, M Mohty, Arnon Nagler
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone marrow transplantation 56 (3) (2020)
Marina Díaz-Beyá, Myriam Labopin, Johan A Maertens, Mahmoud Aljurf, Jakob Passweg, Dietrich Wilhelm Beelen, Harry Schouten, Gerard Socié, Nicolaas P M Schaap, Rainer Schwerdtfeger, Liisa Volin, Mauricette Michallet, Emmanuelle Polge, Jorge Sierra, Florent Malard, Aleksandra Holowiecka, Arnon Nagler, null null
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission. British journal of haematology 189 (5) (2020)
Abdul-Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, Kazimierz Halaburda, Helene Labussiere, Paolo Bernasconi, Wilfried Schroyens, Virginie Gandemer, Nicolaas P M Schaap, Michael Loschi, Pavel Jindra, John A Snowden, Depei Wu, Blandine Guffroy, Montserrat Rovira, Sylvain P Chantepie, Xavier Poire, Lucia Lopez-Corral, Manos Nikolousis, Matteo Pelosini, Fabio Ciceri, Fréderic Baron, Ali Bazarbachi, Selim Corbacioglu, Bipin N Savani, Zinaida Peric, Arnon Nagler, Enric Carreras, Mohamad Mohty
Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party. Bone marrow transplantation 56 (4) (2020)
Arnon Nagler, Bhagirathbhai R Dholaria, Myriam Labopin, Benedetto Bruno, Alessandro Rambaldi, Pietro Pioltelli, Giorgio La Nasa, Gerard Sociè, Stephan Mielke, Marco Ruggeri, Riccardo Saccardi, Georg-Nikolaus Franke, Jürgen Finke, Bipin N Savani, Annalisa Ruggeri, Mohamad Mohty
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. Bone marrow transplantation 56 (1) (2020)
Ali Bazarbachi, Myriam Labopin, Didier Blaise, Edouard Forcade, Gerard Sociè, Ana Berceanu, Emanuele Angelucci, Claude Eric Bulabois, Nicolaus Kröger, Alessandro Rambaldi, Patrice Ceballos, Stephan Mielke, Jean El-Cheikh, Ibrahim Yakoub-Agha, Bipin Savani, Alexandros Spirydonidis, Arnon Nagler, Mohamad Mohty
Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia. Bone marrow transplantation 56 (3) (2020)
Fréderic Baron, Myriam Labopin, Didier Blaise, Maija Itälä-Remes, Gerard Sociè, Edouard Forcade, Ibrahim Yakoub-Agha, Norbert Claude Gorin, Jordi Esteve, Arnon Nagler, Mohamad Mohty
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT. Bone marrow transplantation 56 (2) (2020)
Annalisa Paviglianiti, Myriam Labopin, Didier Blaise, Gerard Sociè, Claude Eric Bulabois, Bruno Lioure, Patrice Ceballos, Igor Wolfgang Blau, Gaelle Guillerm, Johan Maertens, Patrice Chevallier, Anne Huynh, Pascal Turlure, Eric Deconinck, Edouard Forcade, Arnon Nagler, Mohamad Mohty
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT. Bone marrow transplantation 56 (5) (2020)
Sebastian Giebel, Myriam Labopin, Małgorzata Sobczyk-Kruszelnicka, Matthias Stelljes, Jenny L Byrne, Nathalie Fegueux, Dietrich W Beelen, Montserrat Rovira, Alexandros Spirydonidis, Didier Blaise, Martin Bornhäuser, Ihsan Karadogan, Bipin P Savani, Arnon Nagler, Mohamad Mohty, null null
Total body irradiation + fludarabine compared to busulfan + fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 56 (2) (2020)
Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, Ludovic Gabellier, Hélène Labussière-Wallet, Bruno Lioure, Dietrich Beelen, Jan Cornelissen, Gerald Wulf, Pavel Jindra, Hervé Tilly, Jakob Passweg, Riita Niittyvuopio, Gesine Bug, Christophe Schmid, Arnon Nagler, Sebastian Giebel, Mohamad Mohty
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone marrow transplantation 56 (5) (2020)
Sebastian Giebel, Myriam Labopin, Gerard Socié, David Beauvais, Stefan Klein, Eva Maria Wagner-Drouet, Didier Blaise, Stephanie Nguyen-Quoc, Jean Henri Bourhis, Anne Thiebaut, Hélène Labussière-Wallet, Amandine Charbonnier, Ana Berceanu, José Luis Diez-Martin, Nathalie Fegueux, Aleksandra Holowiecka, Arnon Nagler, Mohamad Mohty
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 56 (5) (2020)
Jaime Sanz Caballer, Myriam Labopin, Miguel Angel Sanz, Mahmoud Aljurf, Aida Botelho Sousa, Charles F Craddock, Tsila Zukerman, Hélène Labussière-Wallet, Antonio Campos, Giovanni Grillo, Zubeyde Nur Ozkurt, J J Cornelissen, Péter Reményi, Massimo Martino, Rocio Parody Porras, Arnon Nagler, Norbert-Claude Gorin, Mohamad Mohty, null null
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission. Bone marrow transplantation 56 (6) (2020)

Myriam Labopin.css-eqlu8i{font-size:small;padding-left:4px;} (M Labopin)

Publication Activity (10 Years)

Top Topics

Top Venues

Myriam Labopin (M Labopin)